Health Desk- 10 Sep, 2019: Gary Null & Richard Gale have documented that Google now has a pharmaceutical division headed by GlaxosSmithKline’s former chairman of its global vaccine business. Null & Gale write:
Google today is not only a weapon for promoting the pharmaceutical agenda but now also a drug company itself. During the past six years, Google’s parent company Alphabet has launched two pharmaceutical companies.
In 2013, it founded Calico, run by Genentech’s former CEO Arthur Levinson. Calico operates an R&D facility in the San Francisco Bay Area for the discovery of treatments associated with age-related diseases. Two years later, Alphabet founded Verily Life Sciences (previously Google Life Sciences).
Both pharma companies are partnering with other drug corporations. Recently, Verily has partnered with the European pharmaceutical giant GlaxoSmithKline to form a new drug company, Galvani Bioelectronics for the development of “bioelectronic medicines.”
The collaboration is costing the companies $715 million, and the new firm is being chaired by Glaxo’s former chairman of its global vaccines business.